BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11721691)

  • 1. Pituitary production of prolactin and prolactin-suppressing drugs.
    Tansey MJ; Schlechte JA
    Lupus; 2001; 10(10):660-4. PubMed ID: 11721691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation of hyperprolactinemia.
    Luciano AA
    J Reprod Med; 1999 Dec; 44(12 Suppl):1085-90. PubMed ID: 10649815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current diagnosis and treatment of hyperprolactinemia].
    Melgar V; Espinosa E; Sosa E; Rangel MJ; Cuenca D; Ramírez C; Mercado M
    Rev Med Inst Mex Seguro Soc; 2016; 54(1):111-21. PubMed ID: 26820213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic evaluation of hyperprolactinemia.
    Biller BM
    J Reprod Med; 1999 Dec; 44(12 Suppl):1095-9. PubMed ID: 10649817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The reaction of the hypophysis to thyroliberin and metoclopramide in women with hyperprolactinemia].
    Tkachenko NN; Potin VV; Beskrovnyĭ SV; Nosova LG
    Probl Endokrinol (Mosk); 1990; 36(2):35-40. PubMed ID: 2114023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinemia: pathophysiology and therapeutic approach.
    Capozzi A; Scambia G; Pontecorvi A; Lello S
    Gynecol Endocrinol; 2015 Jul; 31(7):506-10. PubMed ID: 26291795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperprolactinemia].
    Oesterle M; Galeazzi RL
    Praxis (Bern 1994); 1995 Jun; 84(25-26):778-83. PubMed ID: 7597365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speed of response to dopaminergic agents in prolactinomas.
    Hage C; Salvatori R
    Endocrine; 2022 Mar; 75(3):883-888. PubMed ID: 34846682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactinomas.
    Glezer A; Bronstein MD
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hypothyroidism presenting with amenorrhea, galactorrhea, hyperprolactinemia and enlarged pituitary].
    Tadmor OP; Barr I; Diamant YZ
    Harefuah; 1992 Jan; 122(2):76-8. PubMed ID: 1572562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperprolactinemia and infertility.
    Shibli-Rahhal A; Schlechte J
    Endocrinol Metab Clin North Am; 2011 Dec; 40(4):837-46. PubMed ID: 22108283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with primary hypothyroidism presenting as prolactinomas.
    Grubb MR; Chakeres D; Malarkey WB
    Am J Med; 1987 Oct; 83(4):765-9. PubMed ID: 3674063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinemia and prolactinoma.
    Romijn JA
    Handb Clin Neurol; 2014; 124():185-95. PubMed ID: 25248588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary prolactin-secreting tumor formation: recent developments.
    Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
    Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the diagnosis and treatment of hyperprolactinemia.
    Biller BM; Luciano A; Crosignani PG; Molitch M; Olive D; Rebar R; Sanfilippo J; Webster J; Zacur H
    J Reprod Med; 1999 Dec; 44(12 Suppl):1075-84. PubMed ID: 10649814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical prolactin response to growth hormone-releasing hormone in a patient with hyperprolactinemia and empty sella.
    Imai Y; Shimizu T; Sawano S; Ozawa Y; Watanabe T; Shishiba Y
    Endocrinol Jpn; 1991 Apr; 38(2):183-6. PubMed ID: 1752237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperprolactinaemia.
    Prabhakar VK; Davis JR
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):341-53. PubMed ID: 17889620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Giant prolactinomas, a detailed analysis of 196 adult cases.
    Lisa B; Arno V; Christophe B; Heyning Paul V; Carlien H
    Pituitary; 2023 Oct; 26(5):529-537. PubMed ID: 37544978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of prolactin and the role of dopamine agonists: A review.
    Kirsch P; Kunadia J; Shah S; Agrawal N
    Front Endocrinol (Lausanne); 2022; 13():1002320. PubMed ID: 36246929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperprolactinemia after menopause: Diagnosis and management.
    Auriemma RS; Pirchio R; Pivonello R; Colao A
    Maturitas; 2021 Sep; 151():36-40. PubMed ID: 34446277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.